Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

19%

3 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
7(63.6%)
Phase 4
3(27.3%)
Early Phase 1
1(9.1%)
11Total
N/A(7)
Phase 4(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT07326657Phase 4Enrolling By Invitation

Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns

Role: lead

NCT07286123Recruiting

Gender Affirming Vaginoplasty With Tubularized Augmented Peritoneal Cap (TAPCap) Utilizing Fish Skin Xenograft (Kerecis™)

Role: collaborator

NCT06697925Recruiting

Evaluating the Durability of Closure for Venous Leg Ulcers

Role: lead

NCT06693570Phase 4Recruiting

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

Role: lead

NCT05898711Active Not Recruiting

Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

Role: lead

NCT06073301Phase 4Active Not Recruiting

AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF

Role: lead

NCT06384183Enrolling By Invitation

Kerecis Real-World Fish Skin Graft Registry

Role: lead

NCT05898698Active Not Recruiting

Prospective Case Registry for Wounds

Role: lead

NCT01917591Not ApplicableCompleted

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Role: lead

NCT04537520Not ApplicableCompleted

Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

Role: collaborator

NCT04257370Not ApplicableCompleted

Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

Role: lead

NCT04357990Not ApplicableCompleted

Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19

Role: lead

NCT03984331Not ApplicableCompleted

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns

Role: lead

NCT04133493Not ApplicableActive Not Recruiting

Omega3 Wound Fish Skin Graft in the Treatment of DFUs

Role: lead

NCT03664401Early Phase 1Completed

A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing

Role: lead

NCT01348581Not ApplicableCompleted

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Role: lead

All 16 trials loaded